InsightfulValue
← Home

Amgen
Amgen

-8.01%

Healthcare & biotech / Biotechnology and Pharmaceuticals


πŸ”§ Tools

βœ… Due Diligence
πŸ‘€ Insider Trades

Date Type Name A/D Amount Price Security
2025-03-17 F-InKind Graham Jonathan P
officer: EVP & Gen. Counsel & Secy.
D 3150 313.71 Common Stock
2025-03-17 F-InKind Gordon Murdo
officer: EVP, Global Commercial Ops
D 4039 313.71 Common Stock
2025-03-17 F-InKind Bradway Robert A
director, officer: Chairman, CEO and President
D 12853 313.71 Common Stock
2025-03-17 F-InKind Busch Matthew C.
officer: VP, Finance & CAO
D 174 313.71 Common Stock
2025-03-17 ***** *****
***** ***** ***** *****
2025-03-17 ***** *****
***** ***** ***** *****
2025-03-17 ***** *****
***** ***** ***** *****
2025-03-17 ***** *****
***** ***** ***** *****
2025-03-17 ***** *****
***** ***** ***** *****
Amgen

πŸ›οΈ Explore more insider trade data for Amgen!

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal